Short-Term Outcomes following “Switching” to Monthly Ranibizumab in Neovascular Age-Related Macular Degeneration Showing Insufficient Response to Bimonthly Aflibercept
Background/Objectives. To evaluate the efficacy of switching to monthly ranibizumab in neovascular age-related macular degeneration (nAMD) showing an insufficient response to bimonthly aflibercept. Subjects/Methods. A total of 13 nAMD eyes showing an insufficient treatment response to three successi...
Saved in:
| Main Authors: | Jong Suk Lee, Hyun Goo Kang, Christopher Seungkyu Lee, Se Joon Woo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2021/5547686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept
by: Wajiha J Kheir, et al.
Published: (2025-01-01) -
Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01) -
Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
by: Beata Urban, et al.
Published: (2020-01-01) -
OCT predictors of retinal atrophy in neovascular age-related macular degeneration treated with aflibercept
by: Oscar M. Gagliardi, et al.
Published: (2025-04-01) -
Peptide‐Bound Aflibercept Eye Drops for Treatment of Neovascular Age‐Related Macular Degeneration in Nonhuman Primates
by: Xingyan Fan, et al.
Published: (2025-03-01)